Related references
Note: Only part of the references are listed.Molecular Origin of the Binding of WWOX Tumor Suppressor to ErbB4 Receptor Tyrosine Kinase
Brett J. Schuchardt et al.
BIOCHEMISTRY (2013)
PTPN14 interacts with and negatively regulates the oncogenic function of YAP
X. Liu et al.
ONCOGENE (2013)
Biophysical Basis of the Binding of WWOX Tumor Suppressor to WBP1 and WBP2 Adaptors
Caleb B. McDonald et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Structural Features and Ligand Binding Properties of Tandem WW Domains from YAP and TAZ, Nuclear Effectors of the Hippo Pathway
Claire Webb et al.
BIOCHEMISTRY (2011)
WWOX expression in colorectal cancer-a real-time quantitative RT-PCR study
Maciej Jakub Zelazowski et al.
TUMOR BIOLOGY (2011)
WW domain interactions regulate the Hippo tumor suppressor pathway
Z. Salah et al.
CELL DEATH & DISEASE (2011)
Coupling of tandem Smad ubiquitination regulatory factor (Smurf) WW domains modulates target specificity
P. Andrew Chong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Modularity in the Hippo signaling pathway
Marius Sudol et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
YAP At the crossroad between transformation and tumor suppression
Efrem Bertini et al.
CELL CYCLE (2009)
Structure and Function of the Two Tandem WW Domains of the Pre-mRNA Splicing Factor FBP21 (Formin-binding Protein 21)
Xiaojuan Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
WWOX: Its Genomics, Partners, and Functions
Sara Del Mare et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation
Robert W. Woody
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
WWOX in biological control and tumorigenesis
Rami I. Aqeilan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Inactivation of the WWOX gene accelerates forestomach tumor progression in vivo
Rami I. Aqeilan et al.
CANCER RESEARCH (2007)
Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein
John D. Kulman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
WWOX -: the FRA16D cancer gene:: Expression correlation with breast cancer progression and prognosis
E Pluciennik et al.
EJSO (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
WW or WoW: The WW domains in a union of bliss
M Sudol et al.
IUBMB LIFE (2005)
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function
RI Aqeilan et al.
CANCER RESEARCH (2005)
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status
M Nunez et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Loss of WWOX expression in gastric carcinoma
RI Aqeilan et al.
CLINICAL CANCER RESEARCH (2004)
Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level
J Omerovic et al.
EXPERIMENTAL CELL RESEARCH (2004)
Functional association between Wwox tumor suppressor protein and p73, a p53 homolog
RI Aqeilan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The structure and dynamics of tandem WW domains in a negative regulator of notch signaling, suppressor of deltex
OY Fedoroff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins
JH Ludes-Meyers et al.
ONCOGENE (2004)
A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6
C Oostenbrink et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Solution structure and ligand recognition of the WW domain pair of the yeast splicing factor Prp40
S Wiesner et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling
O Ferrigno et al.
ONCOGENE (2002)
Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope
JR Pires et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
Solution structure of a Nedd4 WW domain-ENaC peptide complex
V Kanelis et al.
NATURE STRUCTURAL BIOLOGY (2001)
Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan
X Huang et al.
NATURE STRUCTURAL BIOLOGY (2000)
Share Paper
